Novel artificial endonucleases inhibit base excision repair and potentiate the cytotoxicity of DNA-damaging agents on L1210 cells

Anti-Cancer Drugs

Volumn 10, Issue 1, 1999, Pages 55-65

  Barret, J M ^a   Etievant C ^a   Fahy, J ^a   Lhomme, J ^b   Hill, B T ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b UNIVERSITÉ JOSEPH FOURIER   (France)

Author keywords

Abasic site; Alkylating agents; Artificial endonucleases; Excision repair; Potentiation

Indexed keywords

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CARMUSTINE; DACTINOMYCIN; ENDONUCLEASE; METHOXYAMINE; NITROSOUREA; POLYAMINOACID; PURINE; THIOTEPA;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; EXCISION REPAIR; LEUKEMIA L 1210; METHODOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIZATION;

EID: 0032989828     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199901000-00008     Document Type: Article

References (35)

1. Lehnert M. Clinical multidrug resistance in cancer: a multifactorial problem. Eur J Cancer 1996; 32A: 912-20.
2. Hill BT. Drag resistance: an overview of the current state of the art. Int J Oncol 1996; 9: 197-203.
3. Chancy SG, Sancar A. DNA repair enzymatic mechanisms and relevance to drug response. J Natl Cancer Inst 1996; 88: 1346-60.
4. Lindahl T, Karran P, Wood RD. DNA excision repair pathways. Curr Opin Genet Dev 1997; 7: 158-69.
5. Ludlum DB. DNA alkylation by haloethylnitrosoureas: nature of modifications produced and their enzymatic repair of removal. Mutat Res 1990; 233: 117-26.
6. Engelward BP, Dreslin A, Christensen J, Repair-deficient 3-methyladenine DNA glycosylase homozygous mutant mouse cells have increased sensitivity to alkylation-induced chromosome damage and cell killing. EMBO J 1996; 15: 945-52.
7. Matijasevic Z, Boosalis M, Mackay W, Samson L, Ludlum DB. Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase. Proc Natl Acad Sci USA 1993; 90: 11855-9.
8. 3-methyladenine-DNA-glycosylase in human cells exposed to DMA damaging agents. DNA Cell Biol 1993; 12: 233-41.
9. Ibeanu G, Hartenstein B, Dunn WC, et al. Overexpression of human DNA repair protein N-methylpurine-DNA glycosylase results in the increased removal of N-methylpurines in DNA without a concomitant increase in resistance to alkylating agents in Chinese hamster ovary cells. Carcinogenesis 1992; 13: 1989-95.
10. 6-methylguanine-DNA methyltransferase associated with resistance to alkylating drugs in a mammalian cell line. J Biol Chem 1997; 272: 13250-4.
11. Fornace AJ, Jr, Zmudzka B, Hollander C, Wilson SH. Induction of β-polymerase mRNA by DNA-damaging agents in Chinese hamster ovary cells. Mol Cell Biol 1989; 9: 851-3.
12. Friedman HS, Dolan ME, Kaufmann SH, et al. Elevated DNA polymerase α, DNA polymerase β, and topoisomerase II in a melphalan-resistant rhabdomyosarcoma xenograft that is cross-resistant to nitrosoureas and topotecan. Cancer Res 1994; 54: 3487-93.
13. Gomi A, Shinoda S, Sakai R, et al. Elevated expression of DNA polymerase β gene in glioma cell lines with acquired resistance to 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl)-3-nitrosourea. Biochem Biophys Res Commun 1996; 227: 558-63.
14. Moynihan K, Elion GB, Ali-Osman F, et al. Enhancement of melphalan activity by inhibition of DNA polymerase-α and DNA polymerase-β. Cancer Chemother Pharmacol 1996; 38: 349-54.
15. Xu Y, Moore DH, Broshears J, et al. The apurinic/ apyrimidic endonuclease (APE/ref-1) DNA repair enzyme is elevated in premalignant and malignant cervical cancer. Anticancer Res 1997; 17: 3713-20.
16. Schärer OD, Nash HM, Jiricny J, Laval J, Verdine L. Specific binding of designed pyrrolidine abasic site analog to multiple DNA glycosylases. J Biol Chem 1998; 273: 8592-7.
17. Bouayadi K, Hoffman J-S, Fons P, et al. Overexpression of DNA polymerase β sensitizes mammalian cells to 2′,3′-deoxycytidine and 3′-azido-3′-deoxythymidine. Cancer Res 1997; 57: 110-6.
18. Constant J-F, O'Connor TR, Lhomme J, Laval J. 9-((10(aden-9-yl)-4,8-diazadecyl)amino)-6-chloro-2-methoxy-acridine incises DNA at apurinic sites. Nucleic Acids Res 1988; 16: 2691-703.
19. Constant J-F, Fkyerat A, Demeunynck M, et al. Design of molecules which specifically cleave abasic sites in DNA. Anti-Cancer Drug Des 1990; 5: 59-62.
20. Belmont P, Boudali A, Constant J-F, et al. Efficient and versatile chemical tools for cleavage of abasic sites in DNA. New J Chem 1997; 21: 47-54.
21. Berthet N, Constant J-F, Demeunynck M, Michon P, Lhomme J. Search for DNA repair inhibitators: selective binding of nucleic bases-acridine conjugates to a DNA duplex containing an abasic site. J Med Chem 1997; 40: 3346-52.
22. Fkyerat A, Demeunynck M, Constant J-F, Michon P, Lhomme J. A new class of artificial nucleases that recognize and cleave apurinic sites in DNA with great selectivity and efficiency. J Am Chem Soc 1993; 115: 9952-9.
23. Coppel Y, Constant J-F, Coulombeau C, et al. NMR and molecular modeling studies of the interaction of artificial AP lyases with a DNA duplex containing an apurinic abasic site model. Biochemistry 1997; 36: 4831-43.
24. Barret J-M, Salles B, Provot C, Hill B. Evaluation of DNA repair inhibition by antitumor or antibiotic drugs using a chemiluminescence microplate assay. Carcinogenesis 1997; 18: 2441-5.
25. Fkyerat A, Demeunynck M, Constant J-F, Lhomme J. Synthesis of purine-acridine hybrid molecules related to artificial endonucleases. Tetrahedron 1993; 49: 11237-52.
26. Salles B, Provot C, Calsou P, et al. A chemiluminescent microplate assay to detect DNA damage induced by genotoxic treatments. Anal Biochem 1995; 232: 37-42.
27. Sancar A. DNA repair in humans. Annu Rev Genet 1995; 29: 69-105.
28. Liuzzi M, Talbaert-Borle MA. A new aproach to study of the base-excision repair pathway using methoxyamine. J Biol Chem 1985; 260: 5252-8.
29. Chen SF, Behrens DL, Czerniak PM, et al. XB596, a promising bis-naphtalimide anti-cancer agent. Anti-Cancer Drugs 1993; 4: 447-57.
30. Barzilay G, Walker LJ, Rothwell DG, Hickson ID. Role of the HAP1 protein in repair of oxidative DNA damage and regulation of transcription factors. Br J Cancer 1996; 74: S145-50.
31. Malvy C, Prévost P, Gansser C, Viel C, Paoletti C. Efficient breakage of DNA apurinic sites by indole-amine related 9-amino-ellipticine. Chem-Biol Interact 1986; 57: 41-53.
32. Vasseur JJ, Rayner B, Imbach JL, et al. Structure of the adduct formed between 3-amino-carbazole and the apurinic site oligonucleotide model [Tp(Ap)pT]. J Org Chem 1987; 52: 4994-8.
33. Behmoaras T, Toulmé J-J, Hélène C. A tryptophan-containing peptide recognizes and cleaves DNA at apurinic sites. Nature 1981; 292: 858-9.
34. Grafström RH, Sun T, Doleniak D. AP endonuclease: a possible target for a novel tumoricidal compound. In: Repair and processing of DNA damage 1995: 279.
35. Bobola MS, Berger MS, Stevens B, Silber JR. Variation of DMP840 resistance and relationship to apurinic/apyrimidic endonuclease activity and alkylating agent sensitivity in 12 brain tumor cell lines. Proc Am Ass Cancer Res 1997; 38: 314.